Study setting {9}
The 1366.0021 trial will be conducted at approximately 73 centres across 23 countries worldwide, with approximately two patients randomised at each site. The 1366.0029 trial will be conducted at approximately 44 centres across 17 countries; all of these sites will also participate in the 1366.0021 trial.